Acupressure and Stress Resilience
Using Complementary and Alternative Medicine (CAM) to Promote Stress Resilience in Those With Co-Occurring Mild TBI and PTSD
1 other identifier
interventional
60
1 country
1
Brief Summary
The current study will assess the efficacy of acupressure, a type of complementary and alternative medicine (CAM) in the Veteran population. Veterans with co-occurring mild traumatic brain injury (mTBI) and post-traumatic stress disorder (PTSD) will be consented and randomly assigned to either an active or placebo acupressure treatment series of 8 sessions. The investigators will determine if acupressure affects aspects of day-to-day function, such as memory, sleep, mood, psychiatric health and stress resilience. This information will help identify potential treatment strategies to improve quality of life and overall function in this particular Veteran population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2012
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 5, 2012
CompletedFirst Posted
Study publicly available on registry
June 8, 2012
CompletedStudy Start
First participant enrolled
June 13, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 11, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
March 7, 2017
CompletedMay 19, 2017
May 1, 2017
2.2 years
June 5, 2012
May 18, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Trier Social Stress Test
72 hours post final acupressure treatment
Study Arms (2)
Acupressure Treatment
ACTIVE COMPARATORPlacebo Acupressure Treatment
PLACEBO COMPARATORInterventions
Participant will receive 8 active acupressure treatments.
Participants will receive 8 placebo acupressure treatments.
Eligibility Criteria
You may qualify if:
- Between the ages of 18-60
- Diagnosis of mild TBI and PTSD as assessed by interview and/or chart review
- Currently receiving or eligible to receive physical and/or mental healthcare through the VA Eastern Colorado Health Care System
You may not qualify if:
- History of other significant neurological disease (e.g., Alzheimer's, Parkinson's, multiple sclerosis etc.) as assessed by interview and/or chart review. Such conditions could affect outcome measures independently, thereby creating an experimental confound.
- History or diagnosis of lifetime moderate to severe TBI, as assessed by interview and/or chart review.
- History of psychotic disorder or bipolar I disorder as assessed by structured interview. Such conditions could affect outcome measures independently, thereby creating an experimental confound.
- Inability to read the informed consent document or adequately respond to questions regarding the informed consent procedure.
- Prior experience with acupressure, as this would result in individuals potentially being able to detect Placebo treatments if randomly assigned to that group.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- VA Eastern Colorado Health Care Systemlead
- University of Colorado, Bouldercollaborator
- United States Department of Defensecollaborator
Study Sites (1)
Denver VAMC
Denver, Colorado, 80220, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Theresa D Hernandez, Ph.D.
Senior Investigator and Research Psychologist Eastern Colorado Healthcare System, VISN19, MIRECC
- PRINCIPAL INVESTIGATOR
Lisa A Brenner, Ph.D.
Eastern Colorado Healthcare System VISN 19 MIRECC Director
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of MIRECC (Mental Illness Research, Education and Clinical Center
Study Record Dates
First Submitted
June 5, 2012
First Posted
June 8, 2012
Study Start
June 13, 2012
Primary Completion
August 11, 2014
Study Completion
March 7, 2017
Last Updated
May 19, 2017
Record last verified: 2017-05